Effects of vitamin C on covid-19 patients
Phase 3
- Conditions
- Covid-19.COVID-19virus identifiedU07.1
- Registration Number
- IRCT20220228054146N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Adults (age 18 years or older)
SPO2<92%
Being treated in the ward
Positive PCR test
Involvement of Chest-CT-Scan
Exclusion Criteria
Patients with a history of allergy to vitamin C
Patients with dyspnea caused by cardiogenic pulmonary edema
Pregnant women
Lactating women
Patients with a previous history of end-stage pulmonary disease, end-stage malignant tumor, diabetic ketoacidosis, severe kidney
Active kidney stone disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method